IV immunoglobulin does not reverse established weakness in MS
John H. Noseworthy(Mayo Clinic), Moses Rodriguez(Mayo Clinic), C. Michel Harper(Mayo Clinic in Arizona), Brandon J. Erickson(Mayo Clinic), Brian G. Weinshenker(Mayo Clinic in Arizona), Phillip A. Low(Mayo Clinic), Mark H. Johnson(Birkbeck, University of London), Tanya M. Petterson(Mayo Clinic), L.J. Romme(Mayo Clinic), Ke An(Mayo Clinic), Peter C. O’Brien(University Hospital Crosshouse), Jennifer A. Weis(Mayo Clinic), John Whisnant(Mayo Clinic), Anthony J. Windebank(Mayo Clinic), Kathryn A. Stolp‐Smith(Mayo Clinic)
Cited by 103
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k